Although toxicity has been a major obstacle in developing PI3K inhibitors for the treatment of BC [180], the PI3K signaling pathway plays a vital role in multiple cellular processes related to cell proliferation, survival, and metabolism, and may be therapeutically useful. Here, PIK3CD is linked to breast cancer.